AMCP Partner Session: Understanding and Addressing Racial Disparities in Breast Cancer: A Payer, Provider, Patient, and Policy Analyst Perspective

Pricing: Free for Members and Non-Members

This session is sponsored by Gilead Sciences and is not accredited for continuing pharmacy education contact hours.

 

Course Description

Breast cancer is the most common malignancy in women in the U.S., and the second leading cause of cancer-related death. Although breast cancer death rates have gone down in recent years, they remain higher in Black women.

Despite significant advancements and improvements in triple negative breast cancer (TNBC) outcomes and treatment, disparities persist. Research has shown that compared to white women, Black women have the highest rate of TNBC deaths, lower rates of mammograms, present with more advanced disease at diagnosis, and more often have delays in treatment initiation.

An expert panel of payer, oncologist, patient, and policy analysts with expertise in equity and cancer care will share real-life experiences, provide context on the latest data and polices, and discuss a range of actions which could help payers and manufacturers identify potential needs and solutions to ensure that all women with triple negative breast cancer receive the highest quality, equitable cancer care.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Evaluate your population for any racial disparity in breast cancer prevention, early detection, and treatment to identify actionable strategies to ensure equitable and timely access to care.
  2. Acquire resources and tools, and their related application, to help reduce racial disparities in care.
  3. Explore opportunities for collaboration between the different stakeholders across the care continuum (payers, manufacturers, health care providers, health systems, community and patient advocacy organizations, professional societies, government agencies, and individuals) to close the gap in breast cancer care.
Course summary
Course opens: 
02/15/2023
Course expires: 
12/31/2023
Cost:
$0.00

Faculty

Laura R. Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, FL

Latoya T. Hill, MPH
Senior Policy Analyst
KFF
Washington, DC

Melanie A. Nix, MBA
Cofounder
Breast Cancer Comfort Site and Chief Visionary for Diagnosis to Destiny
Greenbelt, MD

Karen Winkfield, MD, PhD
Executive Director
Meharry-Vanderbilt Alliance
Nashville, TN


Moderator

Porscha Showers, PharmD, AAHIVE
Principal Medical Scientist
Gilead Sciences

Please note this session is not accredited for continuing pharmacy education credit.
 

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Laptop is required to complete this course.